Dalton Transactions, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

The use of bismuth and its compounds in biomedicine has developed rapidly recent years. Due to their unique properties, there are great opportunities for the development new non-invasive strategies early diagnosis effective treatment cancers. This perspective highlights key fabrication methods generate well-defined clinically relevant materials varying characteristics. On one hand, this opens up a wide range possibilities unimodal multimodal imaging. other strategies, which increasingly based on combinatorial therapies, given deal attention. One biggest challenges remains selective tumour targeting, whether active or passive. Here we present an overview developments moving forward from simple enrichment at site via uptake by mononuclear phagocytic system (MPS) more specific targeting covalent modification with tumour-seeking molecules either small antibody-derived molecules.

Язык: Английский